Table of Contents
Table of Contents 3
List of Tables 6
List of Figures 7
AstraZeneca Plc, Medical Equipment, Deals By Year, 2011 to YTD 2017 8
AstraZeneca Plc, Medical Equipment Deals By Type, 2011 to YTD 2017 9
AstraZeneca Plc, Medical Equipment, Deals By Region, 2011 to YTD 2017 10
AstraZeneca Plc, Medical Equipment, Deals By Market, 2011 to YTD 2017 11
AstraZeneca Plc, Medical Equipment, Deals Summary, 2011 to YTD 2017 12
AstraZeneca Plc, Medical Equipment, Deal Details 15
Venture Financing 15
Definiens Raises USD20.3 Million in Venture Financing Round 15
CeraPedics Raises US$19 Million In Series C Financing 17
Definiens Raises US$13 Million In Venture Financing 18
Ambit Biosciences Secures US$30 Million In Series D-2 Financing 19
Partnerships 21
AstraZeneca Enters into Licensing Agreement with Pelago Bioscience 21
AstraZeneca Enters into Agreement with Genedata 22
Chembio Diagnostic Enters into Agreement with AstraZeneca 23
Trovagene Enters into Agreement with AstraZeneca 24
AstraZeneca Enters into Partnership with DNAnexus 25
NeoGenomics and Definiens Enter into Agreement 26
SenzaGen Enters into Agreement with AstraZeneca 27
AgPlus Diagnostics Enters into Agreement with AstraZeneca 28
Indivumed Partners with Definiens 29
Foundation Medicine Enters into Agreement with AstraZeneca 30
Definiens Partners with MolecularMD 31
MedImmune Enters into Agreement with Genisphere 32
Human Longevity Partners with AstraZeneca 33
PROOF Centre Partners with AstraZeneca 34
HighRes Biosolutions Enters into Agreement with AstraZeneca 35
Labcyte Enters into Agreement with AstraZeneca 36
AstraZeneca Enters into Research Agreement with Sutter Health 37
Myriad Genetics Expands Agreement with AstraZeneca 38
Illumina Partners with AstraZeneca, Janssen and Sanofi to Develop NGS-Based Oncology Test System 39
AstraZeneca Enters into Co-Development Agreement with Qiagen 40
AstraZeneca Enters into Co-Development Agreement with Roche 41
Cepheid Enters into Co-Development Agreement with AstraZeneca, Cubist Pharma and GSK 42
Ventana Medical Enters into Co-Development Agreement with MedImmune 43
Definiens Enters Into Agreement With Metamark For ProMark Prognostic Test 44
Myriad Genetics Expands Agreement with AstraZeneca for Olaparib 45
Oxford Cancer Biomarkers Enters Into Agreement With AstraZeneca For Biomarker Discovery 46
AstraZeneca Enters Into Research Agreement With Karolinska Institutet 47
Metamark Genetics Enters Into Co-Development Agreement With Definiens 48
Life Technologies, Oxford Biomedical Research Centre, AstraZeneca And ORD Enter Into Co-Development Agreement 49
Leica Microsystems Enters Into Co-Marketing Agreement With Definiens 50
Definiens Enters Into An Agreement With Cernostics 51
Advanced Cell Diagnostics Enters Into Co-Development Agreement With Definiens 52
Merger 53
AstraZeneca Rumored To Merge With Amgen 53
Debt Offering 54
AstraZeneca Prices Private Placement of 0.875% Notes Due 2021 54
Acquisition 55
Pfizer May Increase Bid to Acquire AstraZeneca 55
MedImmune Acquires Definiens for USD150 Million 57
AstraZeneca Rumored To Acquire Forest Labs For US$15 Billion 58
Celltrion Chairman Jung Jin Seo Plans To Sell Controlling Stake In The Company 59
AstraZeneca To Acquire Remaining 10% Stake In Astrazeneca Pharma India 61
DENTSPLY International Acquires Astra Tech From AstraZeneca For US$1,800 Million 62
AstraZeneca Plc – Key Competitors 64
AstraZeneca Plc – Key Employees 65
AstraZeneca Plc – Locations And Subsidiaries 68
Head Office 68
Other Locations & Subsidiaries 68
Joint Venture 73
Recent Developments 74
Strategy And Business Planning 74
Oct 01, 2017: Molnlycke to establish R&D innovation unit in AstraZeneca’s BioVentureHub 74
Apr 25, 2017: AstraZeneca marks a key milestone with the ‘topping out’ of new global R&D centre and HQ in Cambridge, UK 75
Apr 04, 2016: Heptares Joins Pharma Consortium Applying State of the Art Cryo-Electron Microscopy to Advance Structure Based Drug Discovery 77
Financial Announcements 78
Nov 09, 2017: AstraZeneca Announces Year-To-Date and Q3 2017 Results 78
Jul 27, 2017: AstraZeneca Announce H1 2017 Results 86
Apr 27, 2017: AstraZeneca Announces Q1 2017 Results 95
Feb 02, 2017: Astrazeneca Announces Full-Year and Q4 2016 Results 96
Nov 10, 2016: AstraZeneca: Year-To-Date and Q3 2016 Results 97
Jul 28, 2016: AstraZeneca: H1 2016 Results 109
Apr 29, 2016: AstraZeneca announces 1st Quarter 2016 Results 120
Apr 29, 2016: AstraZeneca Announces Q1 2016 Results 131
Feb 04, 2016: Full-Year and Q4 2015 Results 133
Feb 04, 2016: AstraZeneca Full-Year and Q4 2015 Results 135
Corporate Communications 148
Dec 01, 2017: Faron Pharmaceuticals Oy: Appointment of Chief Commercial Officer 148
Sep 05, 2017: Astrazeneca Appoints Sheri Mccoy and Deborah Disanzo to its Board 149
Aug 16, 2017: Astrazeneca Non-executive Director Retirement 151
Jul 31, 2017: AstraZeneca and MedImmune strengthen immuno-oncology leadership with appointment of two renowned experts31 July 2017 152
Jun 29, 2017: Astra Zeneca: Outcome of the meeting of board of directors held on June 29, 2017 153
May 31, 2017: AstraZeneca appoints Professor Nazneen Rahman to its Board of Directors and Science Committee 154
Mar 06, 2017: Changes to AstraZeneca Board of Directors 155
Nov 09, 2016: Change To Astrazeneca Board Of Directors 156
Sep 28, 2016: Change To Astrazeneca Board Of Directors 157
Product News 158
Sep 20, 2016: Can drag and drop cancer simulation speed up drug discovery 158
Aug 08, 2016: AstraZeneca Diabetes Diet and Lifestyle Support Program, Fit2Me, Extends to Include Cardiovascular Health 160
May 27, 2016: Blood test supports use of potential new treatment for patients with stomach cancer 161
May 05, 2016: Preliminary results comparing PD-L1 IHC diagnostic assays in lung cancer released 163
Feb 16, 2016: Data analysis platform driving preclinical modelling capabilities in AstraZeneca launched to wider pharmaceutical industry 164
Other Significant Developments 165
Nov 01, 2017: CN Bio Innovations announces research collaboration with AstraZeneca to validate a new in vitro tool to predict optimised drug dosing regimens for multi-drug therapies 165
Sep 27, 2017: Inhalation Sciences gets large order from AstraZeneca 166
Jun 06, 2017: AstraZeneca Selects ArisGlobal LifeSphere Safety – Risk Management 167
Mar 31, 2017: First Collaborative Definition of Patient Centricity, Co-created by AstraZeneca with Patients and Carers, Is Published in British Medical Journal 168
Nov 29, 2016: Cytel and AstraZeneca Early Clinical Development Software Collaboration Facilitates Clinical Development Decision-Making 169
Sep 21, 2016: AstraZeneca Selects LLamasoft as Supply Chain Design Partner of Choice 170
Appendix 171
Methodology 171
About GlobalData 171
Contact Us 171
Disclaimer 171
AstraZeneca Plc, Medical Equipment, Key Facts, 2016 2
AstraZeneca Plc, Medical Equipment, Deals Summary, 2011 to YTD 2017 2
AstraZeneca Plc, Medical Equipment, Deals By Year, 2011 to YTD 2017 8
AstraZeneca Plc, Medical Equipment Deals By Type, 2011 to YTD 2017 9
AstraZeneca Plc, Medical Equipment, Deals By Region, 2011 to YTD 2017 10
AstraZeneca Plc, Deals By Market, 2011 to YTD 2017 11
AstraZeneca Plc, Medical Equipment, Deals Summary, 2011 to YTD 2017 12
Definiens Raises USD20.3 Million in Venture Financing Round 15
CeraPedics Raises US$19 Million In Series C Financing 17
Definiens Raises US$13 Million In Venture Financing 18
Ambit Biosciences Secures US$30 Million In Series D-2 Financing 19
AstraZeneca Enters into Licensing Agreement with Pelago Bioscience 21
AstraZeneca Enters into Agreement with Genedata 22
Chembio Diagnostic Enters into Agreement with AstraZeneca 23
Trovagene Enters into Agreement with AstraZeneca 24
AstraZeneca Enters into Partnership with DNAnexus 25
NeoGenomics and Definiens Enter into Agreement 26
SenzaGen Enters into Agreement with AstraZeneca 27
AgPlus Diagnostics Enters into Agreement with AstraZeneca 28
Indivumed Partners with Definiens 29
Foundation Medicine Enters into Agreement with AstraZeneca 30
Definiens Partners with MolecularMD 31
MedImmune Enters into Agreement with Genisphere 32
Human Longevity Partners with AstraZeneca 33
PROOF Centre Partners with AstraZeneca 34
HighRes Biosolutions Enters into Agreement with AstraZeneca 35
Labcyte Enters into Agreement with AstraZeneca 36
AstraZeneca Enters into Research Agreement with Sutter Health 37
Myriad Genetics Expands Agreement with AstraZeneca 38
Illumina Partners with AstraZeneca, Janssen and Sanofi to Develop NGS-Based Oncology Test System 39
AstraZeneca Enters into Co-Development Agreement with Qiagen 40
AstraZeneca Enters into Co-Development Agreement with Roche 41
Cepheid Enters into Co-Development Agreement with AstraZeneca, Cubist Pharma and GSK 42
Ventana Medical Enters into Co-Development Agreement with MedImmune 43
Definiens Enters Into Agreement With Metamark For ProMark Prognostic Test 44
Myriad Genetics Expands Agreement with AstraZeneca for Olaparib 45
Oxford Cancer Biomarkers Enters Into Agreement With AstraZeneca For Biomarker Discovery 46
AstraZeneca Enters Into Research Agreement With Karolinska Institutet 47
Metamark Genetics Enters Into Co-Development Agreement With Definiens 48
Life Technologies, Oxford Biomedical Research Centre, AstraZeneca And ORD Enter Into Co-Development Agreement 49
Leica Microsystems Enters Into Co-Marketing Agreement With Definiens 50
Definiens Enters Into An Agreement With Cernostics 51
Advanced Cell Diagnostics Enters Into Co-Development Agreement With Definiens 52
AstraZeneca Rumored To Merge With Amgen 53
AstraZeneca Prices Private Placement of 0.875% Notes Due 2021 54
Pfizer May Increase Bid to Acquire AstraZeneca 55
MedImmune Acquires Definiens for USD150 Million 57
AstraZeneca Rumored To Acquire Forest Labs For US$15 Billion 58
Celltrion Chairman Jung Jin Seo Plans To Sell Controlling Stake In The Company 59
AstraZeneca To Acquire Remaining 10% Stake In Astrazeneca Pharma India 61
DENTSPLY International Acquires Astra Tech From AstraZeneca For US$1,800 Million 62
AstraZeneca Plc, Key Competitors 64
AstraZeneca Plc, Key Employees 65
AstraZeneca Plc, Subsidiaries 68
AstraZeneca Plc, Joint Venture 73